criteria for semaglutide Inclusion and exclusion the FLOW study Who Can Use Semaglutide for

[DOI] [PMC free article] [PubMed] [Google Scholar] 10.Stempniewicz N., Vassalotti J.A., Cuddeback J.K., et al

The larger point is this: Obesity is increasingly being treated like a medical condition that deserves treatment

The link between GLP-1 and gallbladder problems is real but modest: semaglutide, tirzepatide, and liraglutide raise the risk of gallstones and biliary disease by a small absolute amount, driven mostly by how much weight you lose and how fast, plus a direct slowing of gallbladder emptying

When included in a weight loss plan, semaglutide can aid in weight loss and reduce complications associated with weight loss

While long-term clinical studies are ongoing, we can be carefully optimistic that improved GLP-1-based pharmacology can one day be safely applied to further lower body weight relative to currently available GLP-1R agonists

But they contribute almost nothing to muscle preservation, and the people who stall at week four on semaglutide often share this pattern